NCT06228066 2026-03-17
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
Clinical Trials
5 trialsNCT07155174 2026-03-17
SEZanne
AbbVie
Phase 2 Recruiting
NCT07328425 2026-01-12
ISG-TULIPS
Italian Sarcoma Group
Phase 2 Recruiting
NCT05578326 2025-07-08
Study of Trilaciclib and Lurbinectidin
UNC Lineberger Comprehensive Cancer Center
Phase 2 Recruiting
NCT05800587 2025-04-04
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
Fox Chase Cancer Center
Phase 2 Recruiting